Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3- to 4.5-Hour Window: Joint Outcome Table Analysis of the ECASS 3 Trial

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Stroke

• Publication date

  2009-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/STROKEAHA.108.543561PMID 19498197PMCID PMC2724988
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment Time-Specific Number Needed to Treat Estimates for Tissue Plasminogen Activator Therapy in Acute Stroke Based on Shifts Over the Entire Range of the Modified Rankin Scale

  2009cited by this paper
• Outcome Analysis in Clinical Trial Design for Acute Stroke: Physicians’ Attitudes and Choices

  2008cited by this paper
• Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

  2008cited by this paper
• Hemorrhage After Thrombolytic Therapy for Stroke: The Clinically Relevant Number Needed to Harm

  2007cited by this paper
• Thrombolytic therapy for acute ischemic stroke: the likelihood of being helped versus harmed.

  2007cited by this paper
• Clinical Impact of NXY-059 Demonstrated in the SAINT I Trial: Derivation of Number Needed to Treat for Benefit Over Entire Range of Functional Disability

  2007cited by this paper
• Deriving number-needed-to-treat and number-needed-to-harm from the SAINT I trial results.

  2007cited by this paper
• Novel End Point Analytic Techniques and Interpreting Shifts Across the Entire Range of Outcome Scales in Acute Stroke Trials

  2007cited by this paper
• Relationships between long-term stroke disability, handicap and health-related quality of life.

  2006cited by this paper
• Time Is Brain—Quantified

  2006cited by this paper
• Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke.

  2004cited by this paper
• Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

  2004cited by this paper
• Assessment of post-stroke quality of life in cost-effectiveness studies: The usefulness of the Barthel Index and the EuroQoL-5D

  2004cited by this paper
• Thrombolysis for acute ischaemic stroke.

  2003cited by this paper
• Bioweapons

  2002cited by this paper
• Commentary: Thrombolysis in stroke: It works!

  2002cited by this paper
• Number needed to treat (NNT): estimation of a measure of clinical benefit

  2001cited by this paper
• Early stroke treatment associated with better outcome: the ninds rt-pa stroke study

  2000cited by this paper
• Users' guides to the medical literature: XX. Integrating research evidence with the care of the individual patient. Evidence-Based Medicine Working Group.

  2000cited by this paper
• Utilities for major stroke: results from a survey of preferences among persons at increased risk for stroke.

  1998cited by this paper
• Interpreting treatment effects in randomised trials

  1998cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1996cited by this paper
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper
• Users' guides to the medical literature.

  1993cited by this paper

• Atrial fibrillation is associated with increased in-hospital mortality and complications after IV t-PA in acute ischemic stroke: evidence from the China Stroke Center Alliance (CSCA)

  2026cites this paper
• Efficacy and Safety of Recombinant Human Prourokinase in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2025influential citation
• Noninvasive imaging biomarker reveals invisible microscopic variation in acute ischaemic stroke (≤ 24 h): a multicentre retrospective study

  2025cites this paper
• Endovascular therapy for acute vertebrobasilar occlusion (VERITAS): a systematic review and individual patient data meta-analysis.

  2024cites this paper
• Opinion: can we bust the fear of symptomatic intracerebral hemorrhage due to tPA?

  2024cites this paper
• Task Force Dyspnoe Unit (DU)

  2023cites this paper
• Rapid Thrombolysis Protocol: Results from a Before-and-after Study

  2022cites this paper
• Stroke severity modified the effect of chronic atrial fibrillation on the outcome of thrombolytic therapy

  2021cites this paper
• Post-Stroke Quality of Life Outcomes After Instituting New Stroke Care Quality Indicators

  2021cites this paper
• Neuronal injuries in cerebral infarction and ischemic stroke: From mechanisms to treatment (Review)

  2021cites this paper
• Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis.

  2021cites this paper
• Off-label use of intravenous thrombolysis for acute ischemic stroke: a critical appraisal of randomized and real-world evidence

  2021cites this paper
• Platelets in Thrombo-Inflammation: Concepts, Mechanisms, and Therapeutic Strategies for Ischemic Stroke

  2020cites this paper
• (Neural cell lines derived from teratocarcinoma (NT2N) as graft source for cell transplantation: a new therapeutic strategy for chronic stroke patients)

  2020cites this paper
• Endothelial S1P1 Signaling Counteracts Infarct Expansion in Ischemic Stroke.

  2020cites this paper
• Impact of EMS bypass to endovascular capable hospitals: geospatial modeling analysis of the US STRATIS registry

  2020cites this paper
• Decision-Making Visual Aids for Late, Imaging-Guided Endovascular Thrombectomy for Acute Ischemic Stroke

  2020cites this paper
• Emergency management of stroke in the era of mechanical thrombectomy

  2019cites this paper
• Aus dem Centrum für Schlaganfallforschung Berlin der Medizinischen Fakultät Charité – Universitätsmedizin Berlin DISSERTATION Imaging-Based Predictive Modeling in Acute Ischemic Stroke

  2019cites this paper
• Pedalling-based exercise performance and prevention of post-thrombolysis intracerebral haemorrhage in stroke patients

  2019cites this paper
• Time is Brain: The Future for Acute Ischemic Stroke Management is the Utilization of Steerable Microcatheters for Reperfusion

  2019cites this paper
• Early Collateral Recruitment After Stroke in Infants and Adults.

  2019cites this paper
• Endovascular Treatment of Acute Stroke.

  2019cites this paper
• Constraint-induced movement therapy enhances angiogenesis and neurogenesis after cerebral ischemia/reperfusion

  2019cites this paper
• Racial and Ethnic Disparities in Stroke Care.

  2019cites this paper
• Magnitude of Benefit of Combined Endovascular Thrombectomy and Intravenous Fibrinolysis in Large Vessel Occlusion Ischemic Stroke.

  2019cites this paper
• [Telestroke in Chile: 1 year experience at 7 hospitals].

  2019cites this paper
• Machine Learning in Acute Ischemic Stroke Neuroimaging

  2018cites this paper
• Therapeutic Window Beyond Cerebral Ischemic Reperfusion Injury

  2018cites this paper
• Visual Aids for Patient, Family, and Physician Decision Making About Endovascular Thrombectomy for Acute Ischemic Stroke

  2018cites this paper
• Intravenous Thrombolysis for Acute Ischemic Stroke in a High Complex Regional Hospital

  2018cites this paper
• Intravenous Recombinant Tissue Plasminogen Activator and Ischemic Stroke: Focused Update of 2010 Clinical Practice Advisory From the American Academy of Emergency Medicine.

  2018cites this paper
• Prediction of Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis in Acute Ischemic Stroke: The Symptomatic Intracranial Hemorrhage Score.

  2017cites this paper
• Targeting resolution of neuroinflammation after ischemic stroke with a lipoxin A4 analog: Protective mechanisms and long‐term effects on neurological recovery

  2017cites this paper
• Acute Ischemic Stroke

  2017cites this paper
• Number needed to treat for stroke thrombectomy based on a systematic review and meta-analysis.

  2017cites this paper
• Edad y respuesta a las proteínas mal plegadas en el accidente cerebro vascular. El efecto de la edad = Age and unfolded protein response enhancement in stroke-induced inflammation

  2017cites this paper
• Implementation of stroke teams and simulation training shortened process times in a regional stroke network—A network-wide prospective trial

  2017cites this paper
• Stroke and the heart : a focus on atrial fibrillation and heart failure

  2017cites this paper
• Thrombolytic and Endovascular Therapies for Acute Ischemic Stroke

  2017cites this paper
• Interaction of ARC and Daxx: A Novel Endogenous Target to Preserve Motor Function and Cell Loss after Focal Brain Ischemia in Mice

  2016cites this paper
• Mechanical thrombectomy for emergent large vessel occlusion: a critical appraisal of recent randomized controlled clinical trials

  2016cites this paper
• Safety and Efficacy of Solitaire Stent Thrombectomy

  2016cites this paper
• Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis.

  2016cites this paper
• Time to TreatmentWith Endovascular Thrombectomy andOutcomes From Ischemic Stroke : AMeta-analysis

  2016cites this paper
• Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials.

  2016cites this paper
• [Identification of the factors conditioning times and indicators of quality in the intrahospital care of acute stroke].

  2016cites this paper
• Assessment of dose–effect and therapeutic time window in preclinical studies of rhEGF and GHRP-6 coadministration for stroke therapy

  2016cites this paper
• Facing the Time Window in Acute Ischemic Stroke: The Infarct Core

  2016cites this paper
• Mechanical thrombectomy for acute ischemic stroke

  2016cites this paper
• Endovascular reperfusion therapies for acute ischemic stroke: dissecting the evidence

  2016cites this paper
• The treatment outcome of acute recanalization therapy in acute cerebral infarction

  2016cites this paper
• Accidente cerebrovascular - revisión de la literatura: etiología, diagnóstico, tratamiento general y análisis pediátrico

  2016cites this paper
• An in vitro porcine model evaluating a novel stent retriever for thrombectomy of the common carotid artery

  2016cites this paper
• Mechanical Thrombectomy-Ready Comprehensive Stroke Center Requirements and Endovascular Stroke Systems of Care: Recommendations from the Endovascular Stroke Standards Committee of the Society of Vascular and Interventional Neurology (SVIN)

  2016cites this paper
• [Why is reperfusion therapy delayed in stroke code patients? A qualitative analysis].

  2016cites this paper
• Intravenous Thrombolysis for Acute Ischemic Stroke Within 3 Hours Versus Between 3 and 4.5 Hours of Symptom Onset

  2015cites this paper
• Endovascular Treatment of Acute Ischemic Stroke: New Data, New Truth.

  2015cites this paper
• Targeting platelet receptors in thrombotic and thrombo-inflammatory disorders

  2015cites this paper
• Associations of chronic heart failure with outcome in acute ischaemic stroke patients who received systemic thrombolysis: analysis from VISTA

  2015cites this paper
• Time to endovascular reperfusion and degree of disability in acute stroke

  2015cites this paper
• MR CLEAN: past the tipping point of clinical equipoise.

  2015cites this paper
• Twenty-Year History of the Evolution of Stroke Thrombolysis With Intravenous Alteplase to Reduce Long-Term Disability

  2015cites this paper
• Title Acute Care of Ischemic Stroke Patients in the Hospital Permalink

  2015cites this paper
• Acute Care of Ischemic Stroke Patients in the Hospital

  2015cites this paper
• Acute stroke intervention: a systematic review.

  2015cites this paper
• Cerebral collateral circulation in experimental ischemic stroke: from molecular penumbra to collateral therapeutics

  2015cites this paper
• Acute antithrombotic treatment of ischemic stroke.

  2014cites this paper
• Thrombolysis for acute ischaemic stroke.

  2014cites this paper
• The emerging agenda of stratified medicine in neurology

  2014cites this paper
• Thrombolysis ImPlementation in Stroke (TIPS): evaluating the effectiveness of a strategy to increase the adoption of best evidence practice – protocol for a cluster randomised controlled trial in acute stroke care

  2014cites this paper
• Ischemic Stroke; Acute Treatment

  2014cites this paper
• Effect Size Measures and Their Relationships in Stroke Studies

  2014cites this paper
• Intracerebral hemorrhage in patients treated with intravenous thrombolysis for acute ischemic stroke

  2014cites this paper
• Klinik und Poliklinik für Neuroradiologische Diagnostik und Intervention des Universitätsklinikums Hamburg-Eppendorf

  2013cites this paper
• Unanswered questions in thrombolytic therapy for acute ischemic stroke.

  2013cites this paper
• Does Mechanical Thrombectomy in Acute Embolic Stroke Have Long-term Side Effects on Intracranial Vessels? An Angiographic Follow-up Study

  2013cites this paper
• Systemic thrombolysis for acute ischemic stroke treatment

  2013cites this paper
• siRNA Treatment: “A Sword-in-the-Stone” for Acute Brain Injuries

  2013cites this paper
• Sistemska tromboliza u liječenju akutnog ishemijskog moždanog udara

  2013cites this paper
• Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke.

  2013cites this paper
• Actively developing intravenous thrombolysis for acute ischemic stroke

  2013cites this paper
• Management of ischaemic stroke in the acute setting: review of the current status

  2013cites this paper
• Exploratory analyses to guide inclusion, limitation of sample size and strengthening of endpoints in clinical stroke trials

  2013cites this paper
• Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: the ICARO-2 study.

  2012cites this paper
• Impact of Atrial Fibrillation on Outcome in Thrombolyzed Patients With Stroke: Evidence From the Virtual International Stroke Trials Archive (VISTA)

  2012cites this paper
• Transcranial near-infrared laser therapy applied to promote clinical recovery in acute and chronic neurodegenerative diseases

  2012cites this paper
• Beyond the Time Window of Intravenous Thrombolysis: Standing by or by Stenting?

  2012cites this paper
• Endothelial Cells and Astrocytes: A Concerto en Duo in Ischemic Pathophysiology

  2012cites this paper
• Intravenous Thrombolysis in Expanded Time Window (3-4.5 hours) in General Practice with Concurrent Availability of Endovascular Treatment.

  2012cites this paper
• Eligibility for Intravenous Recombinant Tissue-Type Plasminogen Activator Within a Population: The Effect of the European Cooperative Acute Stroke Study (ECASS) III Trial

  2012cites this paper
• Impact of Protocol Deviations in Acute Ischemic Stroke Treated With Intravenous rt-PA Within 4.5 Hours After Symptom Onset

  2012cites this paper
• [Dysfunction of the blood-brain barrier during ischaemia: a therapeutic concern].

  2012cites this paper
• Warfarin treatment and thrombolysis in acute stroke

  2012cites this paper
• Plasminogen Activators in Ischemic Stroke

  2012cites this paper
• Consenso de Diagnóstico y Tratamiento Agudo del Accidente Cerebrovascular Isquémico Consejo de Stroke - Sociedad Argentina de Cardiología

  2012cites this paper
• Ultrasound-Assisted Tissue Plasminogen Activator Delivery to Ischemic Strokes

  2012influential citation
• La barrière hémato-encéphalique lors de l’ischémie cérébrale : une cible thérapeutique

  2012cites this paper
• Consensus Statement on Diagnosis and Treatment of Acute Ischemic Stroke Stroke Council-Argentine Society of Cardiology

  2012cites this paper
• Aktualne zasady terapii ostrej fazy udaru mózgu

  2011cites this paper